Byline Bancorp Reports Today With Options at a Two-Standard-Deviation Extreme

BY reports Q3 results today at 2 p.m. ET, and the most unusual signal going into the print is not in the borrow market but in options, where the put/call ratio has jumped to a reading more than two standard deviations above its 20-day average, even as short selling remains light and the stock sits near a 52-week high.

Options positioning is the standout. The PCR has risen to 0.0814, against a 20-day mean of 0.0787, a z-score of 2.2 that marks the most defensive relative reading in recent months. The absolute level remains low, meaning calls still far outnumber puts, but the directional shift is notable: relative to its own recent history, demand for downside protection has picked up meaningfully right before the release. The stock itself has held up well, gaining 1.6% on Wednesday to close at $37.99, up 3% on the week and roughly in line with the +2% median across its closest peers.

Short interest, by contrast, tells a quiet story. At 2.8% of the free float, it has drifted lower over the past week and has not moved to a level that would suggest meaningful directional conviction from short sellers. Borrow availability is effectively uncapped, with the lending pool far larger than outstanding short demand. Cost to borrow has eased about 19% over the past week to roughly 0.49%, confirming there is no squeeze pressure and no scramble to establish new short positions ahead of the print.

The analyst picture is broadly positive but stale: the most recent target changes date to late July, when Piper Sandler lifted its target to $46 (Overweight) and Keefe, Bruyette & Woods raised theirs to $41 (Market Perform) following the prior quarter's results. At a current price of $37.99, the consensus mean target of $43.20 implies roughly 14% upside, though that number has not been refreshed in nearly three months. Valuation is modest: the stock trades at about 10.8 times earnings and 1.18 times book, both consistent with a discount to larger regional-bank peers. EPS momentum over the past 30 and 90 days ranks in the 91st and 77th percentiles respectively, and the company has a track record of beating estimates that ranks in the 82nd percentile. The last two quarterly prints each produced gains of roughly 0.3% and 2.8% on the day, with five-day follow-through of 0.4% and 4.3%.

One contextual data point worth noting: FDIC call report data published by the Federal Deposit Insurance Corporation shows that Byline's insured bank charters posted their largest Q2 total assets and total deposits on record (since 2024), at $9.9bn and $7.9bn respectively, covering the quarter ending June 2026. The FDIC dataset has not yet been tested for a measurable lead against BY's reported figures, so it cannot be read as a signal for today's print, but it confirms balance-sheet growth into the period the Q3 report will extend.

On the ownership side, the controlling shareholder Antonio Del Valle Perochena, who holds 25.6% of shares, sold 300,000 shares in early August at $39.10, reducing his stake from 26.7%. The CEO also sold nearly 20,000 shares in mid-August at roughly $39.20, none of it under a pre-arranged 10b5-1 plan. Both directors and a minor insider made small open-market purchases around the same time, but the net 90-day insider position is a disposal of roughly 621,000 shares worth $24.3 million. Wikipedia attention for the stock is running at a z-score of 2.3 against its own 90-day history, suggesting a modest pickup in retail interest ahead of the report.

Today's print will test whether Q3 loan growth and net interest margin can sustain the momentum that pushed BY up 28% year-to-date, and whether management commentary on credit quality justifies trading at a premium to where the Street's targets were last set.